首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Efficacy of Chuanxiong Ding Tong Herbal Formula Granule in the Treatment and Prophylactic of Migraine Patients: A Randomized Double-Blind Multicenter Placebo-Controlled Trial
【2h】

Efficacy of Chuanxiong Ding Tong Herbal Formula Granule in the Treatment and Prophylactic of Migraine Patients: A Randomized Double-Blind Multicenter Placebo-Controlled Trial

机译:川xi定痛中药冲剂对偏头痛患者的治疗和预防作用:一项随机双盲多中心安慰剂对照的试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective. To evaluate the efficacy of traditional Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) for migraine patients with “the Syndrome of Liver Wind and Blood Stasis.” Methods. 150 migraine patients were recruited and assigned randomly in a double-blind, placebo-controlled study to receive CXDT-HFG (n = 99) plus necessary analgesics, or placebo (n = 51) plus necessary analgesics for 16 weeks (12 weeks' intervention and 4 weeks' follow up). Outcome measures included migraine days, frequency of migraine attacks, analgesics consumption for acute treatment, and the proportion of responders as well as the visual analogue scale (VAS) scores and intensity for pain. Results. Compared with the placebo group, the CXDT-HFG group showed significant reduction in migraine days and attacks frequency at week 12 and follow-up period (P < 0.05) as well as in the reduction of VAS scores at follow-up period.There was significant difference in the proportion of responders between the two groups at follow-up period (P = 0.014). However there were no significant differences between the two groups in analgesics consumption (P > 0.05). Conclusion. CXDT-HFG was more effective than placebo in decreasing days of migraine attacks, frequency, VAS scores, and relieving pain intensity for migraine patients.
机译:目的。评估中药川Chu定痛中药配方颗粒(CXDT-HFG)对偏头痛伴“肝风血瘀证”的疗效。方法。招募150名偏头痛患者,并在一项双盲,安慰剂对照研究中随机分配,接受CXDT-HFG(n = 99)加必要的镇痛药,或安慰剂(n = 51)加必要的镇痛药,持续16周(干预12周)和4周的随访)。结果指标包括偏头痛天数,偏头痛发作频率,用于急性治疗的镇痛药消耗量,反应者的比例以及视觉模拟量表(VAS)评分和疼痛强度。结果。与安慰剂组相比,CXDT-HFG组在第12周和随访期间偏头痛天数和发作频率显着减少(P <0.05),并且在随访期间VAS评分降低。随访期间两组之间的应答者比例有显着差异(P = 0.014)。然而,两组之间的镇痛药消耗没有显着差异(P> 0.05)。结论。 CXDT-HFG在减少偏头痛发作的天数,频率,VAS评分和减轻偏头痛患者的疼痛强度方面比安慰剂更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号